BioLineRx Ltd. - American Depositary Shares (BLRX)

Търговски условия

Търговска сесия (UTC)
понеделник: 11:00 - 00:00
вторник - петък: 00:00 - 00:30, 11:00 - 00:00
събота: 00:00 - 00:30

Относно

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

http://www.biolinerx.com